Thursday, March 19, 2026 | 09:55 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 2793 - Markets News

HDFC MF settles the 'regulation violation' case with Sebi, pays Rs 37.9 mn

The settlement was approved by Sebi's high-powered committee in October and subsequently by a panel of whole-time members of Sebi in November

HDFC MF settles the 'regulation violation' case with Sebi, pays Rs 37.9 mn
Updated On : 04 Dec 2018 | 11:48 PM IST

Spurt in loan growth in Oct may not hold as it was led by lending to NBFCs

Surge in October driven by unsecured retail lending and to non-banking financial companies

Spurt in loan growth in Oct may not hold as it was led by lending to NBFCs
Updated On : 04 Dec 2018 | 11:46 PM IST

'NSE goBID' mobile app to make investing in G-secs, T-bills more convenient

Active investors can trade in them once interest rates start to decline

'NSE goBID' mobile app to make investing in G-secs, T-bills more convenient
Updated On : 04 Dec 2018 | 11:37 PM IST

Droom prepares for Nasdaq listing, charts expansion to Southeast Asia

Droom counts Lightbox, Japanese e-commerce firm Beenos and Digital Garage among existing investors

Droom prepares for Nasdaq listing, charts expansion to Southeast Asia
Updated On : 04 Dec 2018 | 9:58 PM IST

Aurobindo Pharma hits 52-week high; up 56% in six months

The stock hit a 52-week high of Rs 830, up 3%, surging 55% in past six months, as compared to 3% rise in the S&P BSE Sensex.

Aurobindo Pharma hits 52-week high; up 56% in six months
Updated On : 04 Dec 2018 | 5:16 PM IST

MARKET WRAP: Sensex slips 107 pts ahead of RBI policy outcome; banks fall

Among the sectoral indices, the Nifty Bank index fell 0.61 per cent weighed by HDFC Bank and State Bank of India (SBI)

MARKET WRAP: Sensex slips 107 pts ahead of RBI policy outcome; banks fall
Updated On : 04 Dec 2018 | 3:49 PM IST

Spot power price plunges 40% to Rs 3.59 per unit in November on low demand

The all India peak demand touched 162 GW on November 2, registering an increase of 9 per cent over November 2017

Spot power price plunges 40% to Rs 3.59 per unit in November on low demand
Updated On : 04 Dec 2018 | 3:31 PM IST

Sun Pharma extends fall despite clarification on corporate governance issue

The stock is down 3% at Rs 442 on Tuesday, extending its 7.5% fall on Monday on the BSE.

Sun Pharma extends fall despite clarification on corporate governance issue
Updated On : 04 Dec 2018 | 3:10 PM IST

Sebi panel plans to allow direct listing of Indian cos on overseas bourses

Currently, Indian companies can list their shares through depository receipts abroad, while foreign companies need to go through the Indian Depository Receipt route for listing of equities

Sebi panel plans to allow direct listing of Indian cos on overseas bourses
Updated On : 04 Dec 2018 | 1:30 PM IST

Kesoram Industries extends rally on talk of demerger; zooms 65% in 3-weeks

The stock moved higher by 8% to Rs 99, rallying 65% from Rs 60 as compared to a 2.6% rise in the S&P BSE Sensex, since November 13, 2018.

Kesoram Industries extends rally on talk of demerger; zooms 65% in 3-weeks
Updated On : 04 Dec 2018 | 12:29 PM IST

Info Edge hits new high; up 22% in seven days

The stock was trading higher for the seventh straight day. It has rallied 5% to Rs 1,695 on the BSE in early morning deal.

Info Edge hits new high; up 22% in seven days
Updated On : 04 Dec 2018 | 11:08 AM IST

Uflex rises 7% as global arm FlexFilms gets US patent for film packaging

Shares of Uflex rose as much as 6.8 per cent to Rs 297 apiece on BSE in the intra-day trade on Tuesday, after the company announced that FlexFilms has been granted US patent for film packaging.

Uflex rises 7% as global arm FlexFilms gets US patent for film packaging
Updated On : 04 Dec 2018 | 11:04 AM IST

Rattled nerves at India Inc lead to boom in overnight funds to Rs 123 bn

Assets with overnight funds soared to Rs 123 billion last month, from Rs 39 billion in September, as companies chose safety over returns

Rattled nerves at India Inc lead to boom in overnight funds to Rs 123 bn
Updated On : 04 Dec 2018 | 9:34 AM IST

Sun Pharma, HUL, Welspun Enterprises among top stocks to track today

Here's a look at the top stocks that may remain in focus in today's session -

Sun Pharma, HUL, Welspun Enterprises among top stocks to track today
Updated On : 04 Dec 2018 | 9:14 AM IST

Rupee opens 3 paise lower at 70.49 against US dollar

Forex dealers said increased dollar demand from importers amid firming global crude oil prices and a strong dollar weighed on the rupee sentiment.

Rupee opens 3 paise lower at 70.49 against US dollar
Updated On : 04 Dec 2018 | 9:13 AM IST

Today's picks: From Hindalco to Sun Pharma, hot stocks to watch on Tuesday

For Sun Pharma, keep a stop at Rs 459 and go short.

Today's picks: From Hindalco to Sun Pharma, hot stocks to watch on Tuesday
Updated On : 04 Dec 2018 | 8:55 AM IST

Buy DCB Bank for a target of Rs 180, SL of Rs 153: Prabhudas Lilladher

Nifty outlook and few trading ideas by Vaishali Parekh, research analyst- technical research at Prabhudas Lilladher.

Buy DCB Bank for a target of Rs 180, SL of Rs 153: Prabhudas Lilladher
Updated On : 04 Dec 2018 | 8:48 AM IST

HUL-GSK Consumer deal is a win-win for shareholders, say analysts

The deal, which is expected to be completed in 12 months, will see the HUL's turnover of foods & refreshments business exceed Rs 100 billion.

HUL-GSK Consumer deal is a win-win for shareholders, say analysts
Updated On : 04 Dec 2018 | 8:40 AM IST

HUL settles at record high, GSK Consumer up 4% after board approves merger

HUL settled 4.1% higher at Rs 1826 on the BSE. It had hit a new high of Rs 1,839 in intra-day trade, rising 4.9%, surpassing its previous high of Rs 1,808 touched on August 20, 2018

HUL settles at record high, GSK Consumer up 4% after board approves merger
Updated On : 04 Dec 2018 | 8:29 AM IST

HUL-GSK deal proves the power of equity, role of premium valuations

In addition to iconic Horlicks brand for Indian as well as international markets, HUL would also own other brands such as Boost, Viva and Maltova

HUL-GSK deal proves the power of equity, role of premium valuations
Updated On : 04 Dec 2018 | 8:29 AM IST